GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cynata Therapeutics CYP.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.02

+25.00%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Cynata Therapeutics — daily ASX:CYP

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Cynata Therapeutics on TradingView ↗
Market value
A$3.1m
Last close × shares
Volume
2m
Shares, 9 Nov 2026

About Cynata Therapeutics

Its shares trade on ASX under the ticker CYP.AX. It has been listed since 20 December 2007. In the fiscal year to 30 June 2026, it reported revenue of A$1.7m and a net loss of A$9.1m. At that date it held total assets of A$1.4m and shareholders' equity of −A$394,240.

Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. The company is headquartered in Melbourne, Victoria. The company went IPO on 2007-12-20. The firm is engaged in the development and commercialization of a mesenchymal stem cell (MSC) technology for human therapeutic use, Cymerus. Its Cymerus technology facilitates manufacture of MSCs from a single donor and a single donation. The firm's Cymerus platform stem cell technology is based upon stem cells known as mesenchymoangioblasts (MCAs). The firm's technology utilizes induced pluripotent stem cells (iPSCs) originating from an adult donor as the starting material for generating MCAs and in turn for manufacturing the MSC therapeutic product. The Cymerus platform provides a source of MSCs that is independent of donor limitations and provides an off-the-shelf stem cell platform for therapeutic product use. The firm's MSCs produced using Cymerus technology, can be used to treat unrelated patients, without any need to match the recipient to the donor.

Figures and description from our data supplier, not checked against the company's own report.

More about Cynata Therapeutics →

Latest on Cynata Therapeutics

Our reporting

We have not reported on Cynata Therapeutics yet.

Next results

25 Feb 2027

Due on 25 Feb 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Cynata Therapeutics's ticker?

Cynata Therapeutics trades as CYP.AX on ASX, under ISIN AU000000CYP7.

What was Cynata Therapeutics's last closing price?

0.02 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Cynata Therapeutics next report results?

Results are expected on 25 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.